Five lupus patients in England have achieved remission after undergoing a revolutionary NHS trial using genetically modified T-cells, with some reporting they no longer need medication to manage their condition, marking a significant step towards a potential cure for the chronic autoimmune disease. New reports highlight patients' positive experiences, reinforcing the therapy's success.

An innovative CAR-T cell therapy, which reprograms T-cells to target harmful cells, has successfully freed a patient from three autoimmune diseases, demonstrating its potential beyond cancer treatments despite high costs.